UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 5
May-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1905Q61


Registration ID:
213459

Page Number

425-437

Share This Article


Jetir RMS

Title

FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF FENOFIBRATE.

Abstract

The aim of this work was to develop a tablet for the buccal delivery of the poorly water-soluble drug Fenofibrate which is a broad spectrum Fibric acid derivative used to reduce cholesterol levels in patients at risk of cardiovascular disease, for that an attempt was made to solubilize Fenofibrate by complexation with β- CD and then delivery via buccal mucosa. HPMC K4M and Carbopol 934P were selected as mucoadhesive polymers while Ethyl cellulose, as backing material. The complexation was studied by phase solubility method which indicates the formation of complex with 1:1 stoichiometry. The complexation was further characterized and studied by FTIR and DSC. Modification of the release for a poorly water-soluble drug, Fenofibrate, from hydrophilic matrices using cyclodextrin complexation was evaluated. The buccoadhesive tablets for the delivery of fenofibrate were prepared by 32 factorial designs by direct compression of HPMC K4M and Carbopol 934P. The tablets were evaluated for in vitro dissolution, surface pH, swelling study and mucoadhesive properties. The surface pH of all formulations was found to be within ±1 units of neutral pH hence these formulations should not cause any irritation in buccal cavity. Carbopol 934P showed superior bioadhesion properties compared to HPMC K4M. The in vitro release results demonstrated that drug is released by non-Fickian diffusion mechanism with zero order kinetics. From the drug release data, it was evident that formulation F2 (containing CP 15mg and HPMC K4M 20mg) has shown highly satisfactory values for dissolution parameters and has released approximatelt 98.53% drug in 6 hr. Hence, formulation F2 considered as the optimized buccal tablet containing Fenofibrate inclusion complex with β- CD for improved bioavailability.

Key Words

Fenofibrate; β- Cyclodextrin; optimization; HPMC K4M; Carbopol 934P; Buccal delivery.

Cite This Article

"FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF FENOFIBRATE.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 5, page no.425-437, May-2019, Available :http://www.jetir.org/papers/JETIR1905Q61.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF FENOFIBRATE.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 5, page no. pp425-437, May-2019, Available at : http://www.jetir.org/papers/JETIR1905Q61.pdf

Publication Details

Published Paper ID: JETIR1905Q61
Registration ID: 213459
Published In: Volume 6 | Issue 5 | Year May-2019
DOI (Digital Object Identifier):
Page No: 425-437
Country: AHMEDABAD, GUJRAT, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002811

Print This Page

Current Call For Paper

Jetir RMS